Test only clinically available at Endeavor Health; Results of study published in April's Circulation: Genomic and Precision Medicine journal EVANSTON, Ill., June 1, 2026 /PRNewswire/ -- Endeavor Health researchers have developed a new, more comprehensive test that can give a clearer picture of patients' genetic risk for coronary artery disease, better known as heart disease. The researchers' results, from biobank data of 450,000 tested individuals, are published in Circulation: Genomic and Preci

JACKSONVILLE, Fla., June 1, 2026 /PRNewswire/ -- Chronic wounds are a growing public health crisis, affecting more than 10 million Americans, including one in six Medicare beneficiaries. Left untreated, they can lead to devastating complications, including infection, hospitalization, and amputation. Yet despite the severity of the problem, too many patients remain unaware that specialized care exists and that earlier treatment can change the course of healing. Continue Reading Wound Care Awarene

Emi-Le recently received Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for the proposed treatment of patients with locally advanced, recurrent or metastatic ACC with solid histology or high-grade transformation Oral presentation shows Emi-Le was well tolerated and showed promising signals of efficacy among 45 evaluable participants with ACC BOSTON, June 1, 2026 /PRNewswire/ -- Servier today announced promising new Phase 1 clinical data for Emi-Le, an investigational a

CHICAGO, June 1, 2026 /PRNewswire/ -- People stop taking medications. They miss appointments. They stop responding to messages. They leave health programs. Sometimes they simply disappear from care. Most healthcare organizations do not know it is happening until months later. By then, the person may have gained weight, stopped treatment, developed complications, or abandoned goals they once felt motivated to achieve. Continue Reading HabitNu Journey Twin Today, HabitNu announced the launch of FA

Allowed patent covers technology designed to elicit an AMHR2-specific immune response for the prevention or treatment of ovarian cancer SAN JOSE, Calif., June 1, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the Canadian Intellectual Property Office (CIPO) has issued a Notice of Allowance for a patent covering key aspects of Anixa's ovarian cancer vaccine tech

Paradigm Health's Scalable Platform for Integrated Research and Evidence (SPIRE) helps trial sponsors generate high-quality clinical trial data across community healthcare practices Columbus, Ohio and CHICAGO, June 1, 2026 /PRNewswire/ -- Paradigm Health today announced its role in the execution of a multicenter, hybrid, observational post-marketing commitment study in the United States evaluating an FDA-approved therapy in patients with human epidermal growth factor receptor 2 (HER2) immunohist

Study spanning all 50 states finds team-based virtual GI care delivers significant symptom improvement, with dietary and behavioral health engagement as key drivers of outcomes NEW YORK, June 1, 2026 /PRNewswire/ -- Oshi Health, the nation's only virtual-first multidisciplinary gastroenterology (GI) clinic, today announced the publication of a peer-reviewed study in the Journal of Medical Internet Research (JMIR) showing that 92.4% of 11,345 patients reported symptom improvement after receiving

Winona launches national research initiative offering funding, mentorship, data support, and publication opportunities for emerging women's health researchers AUSTIN, Texas, June 1, 2026 /PRNewswire/ -- Menopause affects millions of women every year, yet research into menopause and women's health remains significantly underfunded. To help address that gap, Winona, a physician-led telehealth company focused on menopause and perimenopause care, today announced the launch of the Winona Research Ini

CARLSBAD, Calif., June 1, 2026 /PRNewswire/ -- Vitamin C is among the most commonly taken supplements on earth, yet roughly 42% of Americans have inadequate vitamin C levels, as many factors limit absorption, retention, and utilization of this essential nutrient. Qualia brand supplements is releasing their new formula Qualia Vitamin C+ to address the overlooked forms and cofactors that are critical to optimal vitamin C levels, with impressive clinical evidence supporting this new formulation. C

Landmark Committee Has Been Building a Comprehensive Patient Focused Blueprint WASHINGTON, June 1, 2026 /PRNewswire/ -- The Patient First Coalition (PFC), a national coalition of more than 1,100 Ambassadors representing over 50 organizations committed to putting patients first, announced its support for the Drug Enforcement Administration's review and public hearing process regarding the proposed transition of medical cannabis from Schedule I to Schedule III under the Controlled Substances Act.